Phosphoramidates as potent prodrugs of anti-HIV nucleotides: Studies in the amino region

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 1, 1996, Pages 31-36

  McGuigan, C ^a   Cahard, D ^a   Salgado, A ^a   De Clercq, E ^b   Baizarinl, J ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

AZT; d4T; HIV; Nucleotide; Prodrug

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NUCLEOTIDE DERIVATIVE; PHOSPHORAMIDIC ACID DERIVATIVE; PRODRUG; STAVUDINE DERIVATIVE; UNCLASSIFIED DRUG; ZIDOVUDINE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LYMPHOCYTE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030044583     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700106     Document Type: Article

References (19)

1. Balzarini, J., Karlsson, A., Perez-Perez, M.-J., Camarasa, M.-J., Tarpley, W.G., and De Clercp, E. (1993) Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with singledrug therapy. J Virology 67: 5353-5359.
2. Dessaux, C., and Huynh-Dinh, T. (1993) Synthesis of phosphodiester and triester derivatives of AZT with tethered N-methyl piperazine and N,N,N trimethylethylenediamine. Biorg Med Chem Lett 3: 1547-1550.
3. Farrow, S.N., Jones, A.S., Kumar, A., Walker, R.T., Balzarini, J., and De Clercq, E. (1990) Synthesis and biological properties of novel phosphotriesters: A new approach to the introduction of biologically active nucleotides into cells. J Med Chem 33: 1400-1406.
4. Franchetti, P., Cappellacci, L., Grifantini, M., Messini, L., Sheikha, G.A., Loi, A.G., Tramontano, E., De Mentis, A., Spiga, M.G., and La Colla, P. (1994) Synthesis and evaluation of the anti-HIV activity of aza and deaza analogues of isoddA and their phosphates as prodrugs. J Med Chem 37: 3534-3541.
5. Freed, J., Farquhar, D., and Hampton, A. (1989) Evidence for acyloxymethyl esters of pyrimidine 5′-deoxyribonucleotides as extracellular sources of active 5′-deoxyribonucleotides in cultured cells. Biochem Pharmacol 38: 3193-3198.
6. Henin, Y., Gouyette, C., Schwartz, O., Debouzy, J.-C., Neumann, J.-M., and Huynh-Dinh, T. (1991) Lipophilic glycosyl phosphotriester derivatives of AZT: Synthesis, NMR transmembrane transport study and antiviral activity. J Med Chem 34: 1830-1837.
7. Mark, V., Dungan, C.H., Crutchfield, M.M., and Van Wazer, J.R. (1969) Compilation of 31P NMR data. In Topics in Phosphorus Chemistry, vol. 5. M. Grayson, and E.J. Griffith (eds). New York, Wiley. pp. 350-360.
8. McGuigan, C., Nicholls, S.R., O'Connor, T.J., and Kinchington, D. (1990a) Synthesis of some novel dialkylphosphate derivatives of 3′-modified nucleosides as potential anti-AIDS drugs. Antiviral Chem Chemother 1: 25-33.
9. McGuigan, C., O'Connor, T.J., Nicholls, S.R., Nickson, C., and Kinchington, D. (1990b) Synthesis and anti-HIV activity of some novel substituted dialkyl phosphate derivatives of AZT and ddCyd. Antiviral Chem Chemother 1: 355-360.
10. McGuigan, C., Devine, K.G., O'Connor, T.J., Galpin, S.A., Jeffries, D.J., and Kinchington, D. (1990c) Synthesis and evaluation of some novel phosphoramidate derivatives of 3′-azido-3′-deoxythymidine. Antiviral Chem Chemother 1: 107-113.
11. McGuigan, C., Devine, K.G., O'Connor, T.J., and Kinchington, D. (1991) Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3′-azido-3′-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound. Antiviral Res 15: 255-263.
12. McGuigan, C., Pathirana, R.N., Mahmood, N., Devine, K.G., and Hay, A.J. (1992) Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT. Antiviral Res 17: 311-321.
13. McGuigan, C., Pathirana, R.N., Balzarini, J., and De Clercq, E. (1993a) Intracellular delivery of bio-active AZT nucleotides by aryl phosphate derivatives of AZT. J Med Chem 36: 1048-1052.
14. McGuigan, C., Sheeka, H.M., Mahmood, N., and Hay, A. (1993b) Phosphate derivatives of d4T as inhibitors of HIV. Bioorg Med Chem Left 3: 1203-1206.
15. McGuigan, C., Pathirana, R.N., Choi, S.S.-M., Kinchington, D., and O'Connor, T.J. (1993c) Phosphoramidate derivatives of AZT as inhibitors of HIV: studies on the carboxyl terminus. Antiviral Chem Chemother 4: 97-101.
16. McGuigan, C., Pathirana, R.N., Davies, M.P.H., Balzarini, J., and De Clercq, E. (1994a) Diaryl phosphate derivatives act as pro-drugs of AZT with reduced cytotoxicity compared to the parent nucleoside. Bioorg Med Chem Lett 4: 427-430.
17. McGuigan, C., Bellevergue, P., Sheeka, H., Mahmood, N., and Hay, A.J. (1994b) Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully By-pass thymidine kinase. FEBS Lett 351: 11-14.
18. McGuigan, C., Cahard, D., Sheeka, H.M., De Clercq, E., and Balzarini, J. (1996). Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cells. Bioorg Med Chem Lett (in press).
19. Namane, A., Gouyette, C., Fillion, M.-P., Fillion, G., and Huynh-Dinh, T. (1992) Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J Med Chem 35: 3039-3044.